Preclinical identification and clinical validation of dynamic biomarkers for trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer.
- DOI
- 10.1016/j.esmogo.2026.100323
- Published
- 2026 Jun
- Container
- ESMO gastrointestinal oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmogo.2026.100323,
title = {Preclinical identification and clinical validation of dynamic biomarkers for trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer.},
author = {Suenaga M and Mashima T and Kawata N and Dan S and Seimiya H and Yamaguchi K},
year = {2026},
journal = {ESMO gastrointestinal oncology},
doi = {10.1016/j.esmogo.2026.100323},
url = {https://doi.org/10.1016/j.esmogo.2026.100323}
}RIS
TY - JOUR TI - Preclinical identification and clinical validation of dynamic biomarkers for trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer. AU - Suenaga M AU - Mashima T AU - Kawata N AU - Dan S AU - Seimiya H AU - Yamaguchi K PY - 2026 JO - ESMO gastrointestinal oncology DO - 10.1016/j.esmogo.2026.100323 UR - https://doi.org/10.1016/j.esmogo.2026.100323 ER -
APA
M, S., T, M., N, K., S, D., H, S., & K, Y. (2026). Preclinical identification and clinical validation of dynamic biomarkers for trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer.. ESMO gastrointestinal oncology. https://doi.org/10.1016/j.esmogo.2026.100323
Source records
- pubmed · retrieved 2026-09-25T21:23:49.989Z